Unknown

Dataset Information

0

Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein.


ABSTRACT: Neisseria meningitidis remains a leading cause of bacterial sepsis and meningitis. Complement is a key component of natural immunity against this important human pathogen, which has evolved multiple mechanisms to evade complement-mediated lysis. One approach adopted by the meningococcus is to recruit a human negative regulator of the complement system, factor H (fH), to its surface via a lipoprotein, factor H binding protein (fHbp). Additionally, fHbp is a key antigen in vaccines currently being evaluated in clinical trials. Here we characterize strains of N. meningitidis from several distinct clonal complexes which do not express fHbp; all strains were recovered from patients with disseminated meningococcal disease. We demonstrate that these strains have either a frameshift mutation in the fHbp open reading frame or have entirely lost fHbp and some flanking sequences. No fH binding was detected to other ligands among the fHbp-negative strains. The implications of these findings for meningococcal pathogenesis and prevention are discussed.

SUBMITTER: Lucidarme J 

PROVIDER: S-EPMC3122619 | biostudies-literature | 2011 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein.

Lucidarme Jay J   Tan Lionel L   Exley Rachel M RM   Findlow Jamie J   Borrow Ray R   Tang Christoph M CM  

Clinical and vaccine immunology : CVI 20110420 6


Neisseria meningitidis remains a leading cause of bacterial sepsis and meningitis. Complement is a key component of natural immunity against this important human pathogen, which has evolved multiple mechanisms to evade complement-mediated lysis. One approach adopted by the meningococcus is to recruit a human negative regulator of the complement system, factor H (fH), to its surface via a lipoprotein, factor H binding protein (fHbp). Additionally, fHbp is a key antigen in vaccines currently being  ...[more]

Similar Datasets

| S-EPMC4762365 | biostudies-literature
| S-EPMC7671903 | biostudies-literature
| S-EPMC2666550 | biostudies-literature
| S-EPMC5916922 | biostudies-literature
| S-EPMC3668674 | biostudies-literature
| S-EPMC2329792 | biostudies-literature
| S-EPMC6018341 | biostudies-literature
2007-10-11 | GSE7331 | GEO
| S-EPMC4172500 | biostudies-literature
| S-EPMC2801853 | biostudies-literature